XML 32 R23.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2022
Stock-Based Compensation  
Schedule of fair value assumptions

March 31, 

March 31, 

2022

2021

Risk-free interest rate

    

1.69%

    

0.43%

Expected term (in years)

6.06

5.93

Expected volatility

79.17%

77.34%

Expected dividend yield

 

 

Schedule of stock option activity

Weighted

Weighted

Average

Average

Remaining

Number of

Exercise

Contractual

Aggregate

Shares

Price

Term

Intrinsic Value

(in years)

(in thousands)

Outstanding as of December 31, 2021

    

5,768,028

    

$

15.99

    

8.82

    

$

11,365

Granted

2,663,650

7.07

Exercised(1)

(22,744)

4.02

Forfeited

(40,581)

22.39

Outstanding as of March 31, 2022(2)

8,368,353

$

13.16

8.76

$

1,031

Options vested and exercisable as of March 31, 2022

2,138,539

$

13.44

8.29

$

710

Options expected to vest as of March 31, 2022

6,229,814

$

13.06

8.92

$

321

(1)Exercised amount includes vesting of early exercised options.
(2)Balance as of March 31, 2022 includes 39,609 unvested early exercised stock options.
Summary of restricted stock activity

Number of Shares

Grant Date Fair Value

Unvested restricted stock as of December 31, 2021

    

493,185

    

$

2.40

Granted

Vested

(49,318)

2.40

Forfeited

Unvested restricted stock as of March 31, 2022

 

443,867

$

2.40

Schedule of stock-based compensation expense

Three Months Ended March 31, 

2022

2021

Research and development

    

$

3,067

    

$

1,734

General and administrative

 

 

1,898

1,474

Total

 

$

4,965

$

3,208